A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
Screening PSA levels at aged 65-69 may inform the decision to continue or discontinue prostate cancer screening after age 70 years, regardless of patient race and ethnicity. The absolute risks of ...
Prostate-specific antigen (PSA) testing may not accurately pinpoint levels at which transgender women on estrogen therapy may be at risk of developing prostate cancer, according to data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results